GGrantIndex
Sort

141,003 grants matching cytokine

HORMONAL REGULATION OF BLOOD PRESSURE

$2,201,085
Michal Laniado Schwartzman · New York Medical College · P01 · FY2015 · HL

Development of a SARS-CoV-2 vaccine for the elderly by engineering virus-like particles with SARS-CoV-2 antigen and membrane-anchored cytokines

$2,199,976
Christopher Pack · Metaclipse Therapeutics Corporation · N44 · FY2020 · AI

EFRI- BSBA: Novel Microsystems for Manipulation and Analysis of Immune Cells

$2,199,561
Alexander Revzin · University Of California-Davis · · FY2009 · ENG

Translational Immunology research: a support for clinical immunological research

$2,199,118
Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2013 · AR

A major contributor of serious multisystem disease in the elderly: varicella zoster virus-induced inflammation

$2,199,076
Maria Acena Nagel · University Of Colorado Denver · P01 · FY2023 · AG

B Cells in Health and Disease

$2,198,492
Ignacio E. Sanz · University Of Rochester · P01 · FY2010 · AI

Project 1 - Development of mRNA Immunogens for Protective Antibody Induction

$2,197,512
Barton F Haynes · Duke University · U19 · FY2022 · AI

Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets

$2,197,153
D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UH3 · FY2022 · DK

Application of Flow Cytometry to Cell Biology

$2,197,095
Susan Sharrow · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA

Diverse Roles of Reactive Oxygen Species and Inflammation in Vascular Disease

$2,197,055
Kathy K Griendling · Emory University · P01 · FY2013 · HL

INNATE AND ADAPTIVE IMMUNE RESPONSES IN TH2-HIGH ASTHMA

$2,196,448
John V Fahy · University Of California, San Francisco · P01 · FY2014 · HL

CHEMICAL MEDIATORS OF ACUTE PULMONARY DISORDERS

$2,196,379
Brigham And Women'S Hospital · P01 · FY2003 · HL

A deep longitudinal analysis of next generation influenza vaccines in older adults

$2,195,905
Duygu Ucar · Jackson Laboratory · U01 · FY2023 · AI

SPORE in Skin Cancer

$2,195,541
Meenhard Herlyn · Wistar Institute · P50 · FY2008 · CA

Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain

$2,195,014
James Jeffrey Sahn · 4e Therapeutics Inc. · U44 · FY2023 · NS

PHASE II TRIAL OF SLEEP APNEA TREATMENT TO REDUCE CARDIOVASCULAR MORBIDITY

$2,194,820
Susan S Redline · Brigham And Women'S Hospital · RC2 · FY2010 · HL

Role of mitochondria in neurodegenerative diseases

$2,194,533
Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS

Leveraging DNA damage repair pathways as therapeutic targets in womens cancers

$2,194,470
Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

COBRE in Vascular Biology

$2,193,932
Robert E Friesel · Mainehealth · P20 · FY2006 · RR

Regulation of pulmonary inflammation by leukocytes and extracellular matrix

$2,193,311
Steven F Ziegler · Benaroya Research Inst At Virginia Mason · P01 · FY2013 · HL

Genetics and Treatment of Heart Failure in the Young

$2,193,288
Loren J Field · Indiana University Indianapolis · P01 · FY2008 · HL

Establishment of a Bat Resource for Infectious Disease Research

$2,193,256
William A Schountz · Colorado State University · U24 · FY2025 · AI

PICS: A New Horizon for Surgical Critical Care

$2,192,917
Frederick A Moore · University Of Florida · P50 · FY2016 · GM

Precancer Atlas of Familial Adenomatous Polyposis

$2,192,835
Michael P Snyder · Stanford University · U2C · FY2018 · CA

Integrative analysis and modeling of human immune responses and pathologies

$2,192,745
John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI